Efficacy of per-oral endoscopic myotomy for the treatment of non-achalasia esophageal motor disorders.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
12 2020
Historique:
received: 16 07 2019
accepted: 24 12 2019
pubmed: 15 1 2020
medline: 29 5 2021
entrez: 15 1 2020
Statut: ppublish

Résumé

Per-oral endoscopic myotomy (POEM) is effective in achalasia. The objective of this study was to evaluate the short-term clinical efficacy of POEM in non-achalasia esophageal motility disorders (NAEMD). Patients with NAEMD diagnosed by high-resolution manometry were included in a retrospective multicentric study. For each individual case, two controls paired on gender and age were matched: one with type I/II achalasia and one with type III achalasia. The clinical response, defined by an Eckardt score ≤ 3, was assessed at 3 and 6 months. Ninety patients (mean age 66 years, 57 men) were included, 30 patients with NAEMD (13 jackhammer esophagus, 6 spastic esophageal disorders, 4 nutcracker esophagus, and 7 esophagogastric junction obstruction), 30 patients with type I-II achalasia, and 30 patients with type III achalasia. The 3-month response rates were 80% (24/30), 90% (27/30), and 100% (30/30) in NAEMD, type I-II achalasia and type III achalasia, respectively (p < 0.01). Eckardt scores improved from preoperative baseline in all groups (median scores 2.0 after POEM vs. 6.5 before POEM, 1.3 vs. 7.2, and 0.5 vs. 6.1 in NAEMD, type I//I and Type III, respectively). No predictive factor of response was identified. In NAEMD patients, there was a significant improvement of dysphagia, regurgitation, and chest pain scores. The 6-month response rates were 63.2% (12/19), 95.5% (21/22), and 87.0% (20/23) in NAEMD, type I-II achalasia and type III achalasia, respectively (p = 0.03). Although less effective than in achalasia, POEM is an effective treatment for NAEMD. Long-term follow-up data are needed to further confirm that POEM may be a valid treatment of NAEMD.

Identifiants

pubmed: 31932930
doi: 10.1007/s00464-019-07348-y
pii: 10.1007/s00464-019-07348-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5508-5515

Références

Kahrilas PJ, Katzka D, Richter JE (2017) Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA Institute. Gastroenterology 153:1205–1211
doi: 10.1053/j.gastro.2017.10.001 pmcid: 5670013
Inoue H, Minami H, Kobayashi Y, Sato Y, Kaga M, Suzuki M, Satodate H, Odaka N, Itoh H, Kudo S (2010) Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy 42:265–271
doi: 10.1055/s-0029-1244080
Haito-Chavez Y, Inoue H, Beard KW, Draganov PV, Ujiki M, Rahden BHA, Desai PN, Pioche M, Hayee B, Haji A, Saxena P, Reavis K, Onimaru M, Balassone V, Nakamura J, Hata Y, Yang D, Pannu D, Abbas A, Perbtani YB, Patel LY, Filser J, Roman S, Rivory J, Mion F, Ponchon T, Perretta S, Wong V, Maselli R, Ngamruengphong S, Chen YI, Bukhari M, Hajiyeva G, Ismail A, Pieratti R, Kumbhari V, Galdos-Cardenas G, Repici A, Khashab MA (2017) Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol 112:1267–1276
doi: 10.1038/ajg.2017.139
Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE, International High Resolution Manometry Working G (2015) The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 27:160–174
doi: 10.1111/nmo.12477
Zerbib F, Roman S (2015) Current therapeutic options for esophageal motor disorders as defined by the Chicago classification. J Clin Gastroenterol 49:451–460
Mion F, Marjoux S, Subtil F, Pioche M, Rivory J, Roman S, Zerbib F (2019) Botulinum toxin for the treatment of hypercontractile esophagus: results of a double-blind randomized sham-controlled study. Neurogastroenterol Motil 31:e13587
doi: 10.1111/nmo.13587
Vanuytsel T, Bisschops R, Farre R, Pauwels A, Holvoet L, Arts J, Caenepeel P, De Wulf D, Mimidis K, Rommel N, Tack J (2013) Botulinum toxin reduces dysphagia in patients with nonachalasia primary esophageal motility disorders. Clin Gastroenterol Hepatol 11(1115–1121):e1112
Sharata AM, Dunst CM, Pescarus R, Shlomovitz E, Wille AJ, Reavis KM, Swanstrom LL (2015) Peroral endoscopic myotomy (POEM) for esophageal primary motility disorders: analysis of 100 consecutive patients. J Gastrointest Surg 19:161–170
doi: 10.1007/s11605-014-2610-5
Teitelbaum EN, Dunst CM, Reavis KM, Sharata AM, Ward MA, DeMeester SR, Swanstrom LL (2018) Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders. Surg Endosc 32:421–427
doi: 10.1007/s00464-017-5699-2
Khashab MA, Familiari P, Draganov PV, Aridi HD, Cho JY, Ujiki M, Rio Tinto R, Louis H, Desai PN, Velanovich V, Albeniz E, Haji A, Marks J, Costamagna G, Deviere J, Perbtani Y, Hedberg M, Estremera F, Martin Del Campo LA, Yang D, Bukhari M, Brewer O, Sanaei O, Fayad L, Agarwal A, Kumbhari V, Chen YI (2018) Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter study. Endosc Int Open 6:E1031–e1036
doi: 10.1055/a-0625-6288 pmcid: 6086680
Filicori F, Dunst CM, Sharata A, Abdelmoaty WF, Zihni AM, Reavis KM, Demeester SR, Swanstrom LL (2019) Long-term outcomes following POEM for non-achalasia motility disorders of the esophagus. Surg Endosc 33:1632–1639
doi: 10.1007/s00464-018-6438-z
Kane ED, Budhraja V, Desilets DJ, Romanelli JR (2019) Myotomy length informed by high-resolution esophageal manometry (HREM) results in improved per-oral endoscopic myotomy (POEM) outcomes for type III achalasia. Surg Endosc 33:886–894
doi: 10.1007/s00464-018-6356-0
Kumbhari V, Tieu A, Onimaru M, El Zein M, Teitelbaum E, Gitelis M, Modayil R, Hungness ES, Stravopoulos S, Shiwaku H, Kunda R, Chiu P, Saxena P, Messallam A, Inoue H, Khashab M (2015) Peroral endoscopy myotomy vs laparoscopic Heller myotomy for the treatment of type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open 3:E195–E201
doi: 10.1055/s-0034-1391668 pmcid: 4486039
Bechara R, Ikeda H, Inoue H (2016) Peroral endoscopic myotomy for Jackhammer esophagus: to cut or not to cut the lower esophageal sphincter. Endosc Int Open 4:E585–588
doi: 10.1055/s-0042-105204 pmcid: 4892003

Auteurs

Lucie Bernardot (L)

CHU de Bordeaux, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Gastroenterology Department, Université de Bordeaux; INSERM CIC 1401, Bordeaux, France.

Sabine Roman (S)

Hospices Civils de Lyon, Hôpital E Herriot, Gastroenterology, Université de Lyon; Inserm U1032, LabTAU, Lyon, France.

Maximilien Barret (M)

Gastroenterology Department, AP-HP, Hôpital Cochin, Paris, France.

Véronique Vitton (V)

Gastroenterology Department, AP-HM, Hôpital Nord, Marseille, France.

Timothée Wallenhorst (T)

Gastroenterology Department, CHU de Rennes, Rennes, France.

Mathieu Pioche (M)

Hospices Civils de Lyon, Hôpital E Herriot, Gastroenterology, Université de Lyon; Inserm U1032, LabTAU, Lyon, France.

Stanislas Chaussade (S)

Gastroenterology Department, AP-HP, Hôpital Cochin, Paris, France.

Jean-Michel Gonzalez (JM)

Gastroenterology Department, AP-HM, Hôpital Nord, Marseille, France.

Thierry Ponchon (T)

Hospices Civils de Lyon, Hôpital E Herriot, Gastroenterology, Université de Lyon; Inserm U1032, LabTAU, Lyon, France.

Frédéric Prat (F)

Gastroenterology Department, AP-HP, Hôpital Cochin, Paris, France.

Marc Barthet (M)

Gastroenterology Department, AP-HM, Hôpital Nord, Marseille, France.

Julien Vergniol (J)

CHU de Bordeaux, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Gastroenterology Department, Université de Bordeaux; INSERM CIC 1401, Bordeaux, France.

Edouard Chabrun (E)

CHU de Bordeaux, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Gastroenterology Department, Université de Bordeaux; INSERM CIC 1401, Bordeaux, France.

Frank Zerbib (F)

CHU de Bordeaux, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Gastroenterology Department, Université de Bordeaux; INSERM CIC 1401, Bordeaux, France. frank.zerbib@chu-bordeaux.fr.
Gastroenterology and Hepatology Department, Centre Medico-Chirurgical Magellan Haut-Lévêque Hospital, CHU de Bordeaux, Avenue Magellan, 33600, Pessac, France. frank.zerbib@chu-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH